The U.S. Food and Drug Administration has approved Imbruvica (ibrutinib) for pediatric patients with chronic graft versus host disease (cGVHD) after failure of one or more lines of systemic therapy.
Aug 29, 2022
0
13
(HealthDay)—For patients with pulmonary arterial hypertension, the new dual endothelin-receptor antagonist macitentan is associated with reductions in morbidity and mortality, according to a study published in the Aug. ...
Aug 29, 2013
0
0
Peru, a shining star in Latin America's culinary firmament, is battling alarming rates of malnutrition in children and pregnant women.
Oct 6, 2018
0
0
(HealthDay)—New mutations have been identified with next-generation sequencing (NGS) in refractory anemia with ring sideroblasts and thrombocytosis (RARS-T), which are prognostic for survival, according to a study published ...
Feb 22, 2016
1
0
Treatment of anemia caused by chronic kidney disease or other diseases often requires repeated—and costly—injections or infusions of an artificial form of the hormone erythropoietin (EPO), which stimulates production ...
Apr 11, 2018
0
9
A magnetic resonance imaging (MRI)-based machine learning method can distinguish aplastic anemia (AA) from myelodysplastic syndromes (MDS), according to a study published online March 6 in Clinical Radiology.
Apr 24, 2023
0
9
Sickle cell disease is characterized by recurrent episodes of "sickle crisis," also known as vaso-occlusive crisis, in which a patient's red blood cells change shape, clump together and block the flow of blood in small vessels ...
Feb 1, 2017
0
0
Few youths with sickle cell anemia (SCA) receive hydroxyurea despite national guidelines recommending its use, according to a study published online March 24 in JAMA Network Open.
Mar 28, 2023
0
0
First produced only in the past decade, human induced pluripotent stem cells (iPSCs) are capable of developing into many or even all human cell types. In new research, scientists reprogrammed skin cells from patients with ...
Jul 30, 2013
0
0
Testosterone replacement therapy (TRT) is efficacious for correcting anemia among middle-aged and older men with hypogonadism and anemia, according to a study published online Oct. 27 in JAMA Network Open.
Oct 30, 2023
0
0
